Free Trial

Nkarta (NKTX) Financials

Nkarta logo
$1.93 -0.10 (-4.93%)
Closing price 10/15/2026 04:00 PM Eastern
Extended Trading
$1.95 +0.02 (+1.04%)
As of 10/15/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Nkarta

Annual Income Statements for Nkarta

This table shows Nkarta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-21 -91 -86 -114 -117 -108 -104
Consolidated Net Income / (Loss)
-21 -91 -86 -114 -118 -109 -104
Net Income / (Loss) Continuing Operations
-21 -91 -86 -114 -118 -109 -104
Total Pre-Tax Income
-21 -91 -86 -114 -118 -109 -104
Total Operating Income
-22 -52 -86 -119 -132 -128 -122
Total Gross Profit
0.12 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue
0.12 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
22 52 86 119 132 128 122
Selling, General & Admin Expense
5.25 15 23 28 35 31 32
Research & Development Expense
17 36 63 91 97 97 90
Total Other Income / (Expense), net
1.27 -40 0.35 5.12 14 19 18
Interest & Investment Income
0.30 0.31 0.37 5.59 14 19 15
Other Income / (Expense), net
2.19 -40 -0.02 -0.47 0.04 0.09 2.42
Basic Earnings per Share
($14.41) ($5.44) - ($2.61) ($2.40) ($1.60) ($1.41)
Weighted Average Basic Shares Outstanding
1.46M 16.81M 32.86M 43.63M 49.01M 67.87M 73.99M
Diluted Earnings per Share
($14.41) ($5.44) - ($2.61) ($2.40) ($1.60) ($1.41)
Weighted Average Diluted Shares Outstanding
1.46M 16.81M 32.86M 43.63M 49.01M 67.87M 73.99M
Weighted Average Basic & Diluted Shares Outstanding
1.46M 16.81M 32.86M 43.63M 49.42M 70.96M 71.29M
Cash Dividends to Common per Share
- - - - $0.00 $0.00 $0.00

Quarterly Income Statements for Nkarta

This table shows Nkarta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-27 -30 -25 -26 -27 -32 -23 -22 -28 -28 -41
Consolidated Net Income / (Loss)
-28 -30 -25 -28 -26 -32 -23 -22 -27 -28 -40
Net Income / (Loss) Continuing Operations
-28 -30 -25 -28 -26 -32 -23 -22 -27 -28 -40
Total Pre-Tax Income
-28 -30 -25 -28 -26 -32 -23 -22 -27 -28 -40
Total Operating Income
-31 -33 -31 -34 -31 -37 -27 -27 -31 -31 -43
Total Gross Profit
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Revenue
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Cost of Revenue
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses
31 33 31 34 31 37 27 27 31 31 43
Selling, General & Admin Expense
7.86 7.53 7.59 8.54 7.80 12 6.41 7.09 5.68 5.89 14
Research & Development Expense
23 25 23 25 23 24 21 20 25 25 29
Total Other Income / (Expense), net
3.43 3.24 5.72 5.45 4.99 4.58 4.21 5.57 3.55 3.04 2.76
Interest & Investment Income
3.46 3.25 5.72 5.45 4.89 4.38 3.97 3.85 3.30 2.84 2.54
Other Income / (Expense), net
-0.03 -0.00 -0.00 -0.00 0.09 0.21 0.24 1.72 0.26 0.21 0.22
Basic Earnings per Share
($0.57) ($0.58) ($0.34) ($0.39) ($0.29) ($0.43) ($0.31) ($0.29) ($0.38) ($0.37) ($0.54)
Weighted Average Basic Shares Outstanding
49.01M 50.68M 73.49M 73.56M 67.87M 73.92M 73.98M 74.02M 73.99M 74.26M 74.49M
Diluted Earnings per Share
($0.57) ($0.58) ($0.34) ($0.39) ($0.29) ($0.43) ($0.31) ($0.29) ($0.38) ($0.37) ($0.54)
Weighted Average Diluted Shares Outstanding
49.01M 50.68M 73.49M 73.56M 67.87M 73.92M 73.98M 74.02M 73.99M 74.26M 74.49M
Weighted Average Basic & Diluted Shares Outstanding
49.42M 70.47M 70.56M 70.57M 70.96M 70.96M 71.02M 71.03M 71.29M 71.55M 71.62M

Annual Cash Flow Statements for Nkarta

This table details how cash moves in and out of Nkarta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
13 76 -34 -23 -6.45 -3.17 12
Net Cash From Operating Activities
-18 -44 -68 -57 -86 -100 -89
Net Cash From Continuing Operating Activities
-18 -44 -68 -57 -86 -100 -89
Net Income / (Loss) Continuing Operations
-21 -91 -86 -114 -118 -109 -104
Consolidated Net Income / (Loss)
-21 -91 -86 -114 -118 -109 -104
Depreciation Expense
0.40 0.79 1.76 2.64 5.87 9.15 9.19
Amortization Expense
-0.02 0.74 3.24 -0.82 -8.94 -6.91 -4.58
Non-Cash Adjustments To Reconcile Net Income
0.15 47 15 21 23 19 6.20
Changes in Operating Assets and Liabilities, net
2.18 -0.83 -1.64 34 11 -12 4.58
Net Cash From Investing Activities
-18 -210 33 -185 79 -130 100
Net Cash From Continuing Investing Activities
-18 -210 33 -185 79 -130 100
Purchase of Property, Plant & Equipment
-1.93 -7.51 -5.03 -47 -28 -4.41 -1.21
Purchase of Investments
-16 -223 -227 -386 -260 -406 -239
Sale and/or Maturity of Investments
0.00 20 265 248 367 281 340
Net Cash From Financing Activities
50 330 1.20 219 0.69 226 0.14
Net Cash From Continuing Financing Activities
50 330 1.20 219 0.69 226 0.14
Issuance of Common Equity
0.00 265 0.00 2.00 0.53 225 0.14
Other Financing Activities, net
0.05 0.40 1.20 217 0.16 0.67 0.00

Quarterly Cash Flow Statements for Nkarta

This table details how cash moves in and out of Nkarta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-7.22 219 -130 -63 -29 25 0.82 6.70 -20 -12 -4.07
Net Cash From Operating Activities
-23 -29 -22 -25 -25 -30 -19 -19 -22 -28 -24
Net Cash From Continuing Operating Activities
-23 -29 -22 -25 -25 -30 -19 -19 -22 -28 -26
Net Income / (Loss) Continuing Operations
-28 -30 -25 -28 -26 -32 -23 -22 -27 -28 -40
Consolidated Net Income / (Loss)
-28 -30 -25 -28 -26 -32 -23 -22 -27 -28 -40
Depreciation Expense
2.25 2.26 2.26 2.35 2.29 2.30 2.33 2.31 2.26 2.34 2.73
Amortization Expense
-2.03 -1.57 -1.45 -1.96 -1.93 -1.57 -1.21 -0.95 -0.86 -0.75 -0.46
Non-Cash Adjustments To Reconcile Net Income
4.08 4.96 1.63 7.97 1.51 3.32 2.47 3.05 -2.64 2.44 5.93
Changes in Operating Assets and Liabilities, net
0.09 -4.64 0.66 -4.56 -0.68 -1.68 0.63 -1.37 7.00 -4.40 6.28
Net Cash From Investing Activities
16 21 -108 -39 -4.52 54 19 25 1.10 16 21
Net Cash From Continuing Investing Activities
16 21 -108 -39 -4.52 54 19 25 1.10 16 21
Purchase of Property, Plant & Equipment
-6.81 -0.18 -2.35 -0.78 -1.10 -0.52 -0.14 0.01 -0.56 -0.41 -0.18
Purchase of Investments
-63 -40 -174 -106 -86 -21 -69 -58 -91 -54 -42
Sale and/or Maturity of Investments
86 62 69 68 82 75 88 83 93 71 64
Net Cash From Financing Activities
0.30 226 -0.37 0.00 0.18 0.00 0.08 - 0.06 0.01 0.68
Net Cash From Continuing Financing Activities
0.30 226 -0.37 0.00 0.18 0.00 0.08 - 0.06 0.01 0.68
Issuance of Common Equity
0.16 226 -0.46 - 0.19 0.00 0.08 - 0.06 0.00 0.07
Other Financing Activities, net
0.14 0.58 0.09 0.00 -0.00 0.00 - - - 0.01 0.60

Annual Balance Sheets for Nkarta

This table presents Nkarta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
48 338 274 473 379 501 404
Total Current Assets
37 319 246 361 253 273 283
Cash & Equivalents
21 97 61 37 31 28 40
Short-Term Investments
16 218 177 315 217 239 237
Prepaid Expenses
0.47 3.92 7.69 8.55 4.88 5.98 6.23
Plant, Property, & Equipment, net
3.08 9.35 13 62 79 75 67
Total Noncurrent Assets
7.87 9.47 15 50 46 153 55
Long-Term Investments
- - - - 0.00 110 16
Other Noncurrent Operating Assets
7.87 9.47 15 50 46 43 39
Total Liabilities & Shareholders' Equity
48 338 274 473 379 501 404
Total Liabilities
14 16 23 101 106 93 92
Total Current Liabilities
8.17 8.83 13 22 23 19 22
Accounts Payable
1.88 1.18 1.11 1.76 3.67 0.64 2.09
Accrued Expenses
3.29 6.25 9.35 16 14 12 13
Other Current Liabilities
2.99 1.40 2.48 4.25 6.07 6.05 6.89
Total Noncurrent Liabilities
5.91 7.60 9.99 79 82 74 70
Other Noncurrent Operating Liabilities
5.91 7.60 9.99 79 82 74 70
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-25 321 251 372 273 408 312
Total Preferred & Common Equity
-25 321 251 372 273 408 312
Total Common Equity
-25 321 251 372 273 408 312
Common Stock
1.18 439 455 691 709 952 960
Retained Earnings
-27 -118 -204 -318 -435 -544 -648
Accumulated Other Comprehensive Income / (Loss)
-0.00 0.00 -0.15 -0.68 0.01 0.67 0.41

Quarterly Balance Sheets for Nkarta

This table presents Nkarta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
406 577 554 532 471 448 427 372 338
Total Current Assets
281 443 332 290 272 297 289 236 188
Cash & Equivalents
38 250 120 57 53 53 60 27 25
Short-Term Investments
237 187 204 226 213 236 222 203 158
Prepaid Expenses
5.58 5.39 6.98 7.10 6.04 6.88 6.94 5.46 5.28
Plant, Property, & Equipment, net
78 79 78 76 73 70 68 64 57
Total Noncurrent Assets
47 56 145 166 126 81 70 72 93
Long-Term Investments
0.00 9.81 99 119 84 42 31 34 58
Other Noncurrent Operating Assets
47 46 46 46 43 40 38 38 35
Total Liabilities & Shareholders' Equity
406 577 554 532 471 448 427 372 338
Total Liabilities
109 103 101 101 92 91 89 86 90
Total Current Liabilities
26 22 21 22 19 19 19 18 24
Accounts Payable
4.28 3.18 3.76 1.94 1.49 1.51 1.44 1.59 3.82
Accrued Expenses
15 13 12 14 11 11 11 9.54 12
Other Current Liabilities
6.06 6.08 5.53 6.76 5.95 6.91 6.37 7.08 7.28
Total Noncurrent Liabilities
83 81 80 79 73 72 70 68 66
Other Noncurrent Operating Liabilities
83 81 80 79 73 72 70 68 66
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
297 474 453 431 379 358 338 286 248
Total Preferred & Common Equity
297 474 453 431 379 358 338 286 248
Total Common Equity
297 474 453 431 379 358 338 286 248
Common Stock
705 939 943 947 954 956 958 962 965
Retained Earnings
-408 -465 -490 -518 -576 -599 -621 -676 -717
Accumulated Other Comprehensive Income / (Loss)
-0.41 -0.13 -0.26 1.71 0.65 0.36 0.54 -0.13 -0.43

Annual Metrics And Ratios for Nkarta

This table displays calculated financial ratios and metrics derived from Nkarta's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 32,595,397.00 32,949,415.00 48,813,720.00 49,072,342.00 - 71,029,512.00
DEI Adjusted Shares Outstanding
0.00 32,595,397.00 32,949,415.00 48,813,720.00 49,072,342.00 - 71,029,512.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -2.80 -2.61 -2.34 -2.38 - -1.47
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
0.00% -355.92% 9.65% -44.39% -14.52% 6.54% 8.66%
EBIT Growth
0.00% -354.85% 5.70% -38.15% -10.20% 2.66% 6.66%
NOPAT Growth
0.00% -130.47% -67.80% -37.63% -10.67% 2.63% 4.83%
Net Income Growth
0.00% -333.48% 5.79% -32.25% -3.22% 7.41% 4.33%
EPS Growth
0.00% 62.25% 0.00% 0.00% 8.05% 33.33% 11.88%
Operating Cash Flow Growth
0.00% -136.87% -56.13% 16.09% -51.16% -15.71% 11.03%
Free Cash Flow Firm Growth
0.00% 0.00% -48.98% -34.86% -7.44% 2.38% 20.83%
Invested Capital Growth
0.00% 337.28% 104.20% 55.79% 25.08% 20.46% -34.04%
Revenue Q/Q Growth
0.00% -100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% -2.55% 0.00% 0.00% 3.81% 0.40% 1.01%
EBIT Q/Q Growth
0.00% -3.43% 0.00% 0.00% 3.14% 0.30% 0.10%
NOPAT Q/Q Growth
0.00% -12.11% 0.00% 0.00% 2.80% 0.20% -0.03%
Net Income Q/Q Growth
0.00% -2.66% 0.00% 0.00% 3.95% 1.64% -1.44%
EPS Q/Q Growth
0.00% 84.43% 0.00% 0.00% 2.44% 14.89% -6.82%
Operating Cash Flow Q/Q Growth
0.00% -16.68% -7.46% 15.23% -22.85% -1.42% 3.38%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 2.26% 7.47%
Invested Capital Q/Q Growth
0.00% 20.78% 0.00% 0.00% 18.36% 6.63% -17.43%
Profitability Metrics
- - - - - - -
Gross Margin
100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
-17,193.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
-19,433.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
-17,526.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
-18,326.96% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
104.57% 99.66% 99.57% 95.32% 89.28% 84.92% 87.04%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-61.39% -51.39% -30.09% -36.53% -36.41% -31.94% -28.90%
Cash Return on Invested Capital (CROIC)
0.00% -713.82% -699.18% -549.15% -430.41% -342.95% -299.42%
Operating Return on Assets (OROA)
-41.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
-43.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
45.56% -42.75% -30.09% -36.53% -36.41% -31.94% -28.90%
Return on Equity Simple (ROE_SIMPLE)
82.71% -28.44% -34.30% -30.58% -43.00% -26.67% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -36 -61 -83 -92 -90 -85
NOPAT Margin
-13,603.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-14.68% -31.43% -9.25% -10.36% -8.44% -6.09% -5.58%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -33.72% -22.00% -27.34%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
4,562.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
14,971.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19,533.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-20 -92 -86 -119 -132 -128 -120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-20 -90 -81 -118 -135 -126 -115
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 6.24 2.02 0.79 1.19 0.43 0.42
Price to Tangible Book Value (P/TBV)
0.00 6.24 2.02 0.79 1.19 0.43 0.42
Price to Revenue (P/Rev)
1,565.22 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 267.75 20.78 0.00 3.02 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
1,763.69 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.08 -0.99 -0.97 -0.95 -0.93 -0.92 -0.93
Leverage Ratio
1.41 1.09 1.07 1.20 1.32 1.29 1.26
Compound Leverage Factor
1.47 1.08 1.06 1.14 1.18 1.10 1.09
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
174.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-74.22% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.25 72.89 12.17 0.83 -0.19 -0.62 -1.59
Noncontrolling Interest Sharing Ratio
174.22% 16.82% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
4.59 36.10 18.99 16.36 10.85 14.45 12.69
Quick Ratio
4.53 35.66 18.40 15.97 10.64 14.13 12.41
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -45 -67 -90 -97 -95 -75
Operating Cash Flow to CapEx
-952.65% -579.23% -1,351.78% -120.99% -306.11% -2,261.19% -7,342.63%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-14.99 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-16.57 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.04 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - -
Invested Capital
-2.66 6.31 13 20 25 30 20
Invested Capital Turnover
-0.04 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 8.97 6.57 7.19 5.03 5.13 -10
Enterprise Value (EV)
203 1,689 268 -60 76 -202 -161
Market Capitalization
180 2,004 506 292 324 176 131
Book Value per Share
($17.42) $9.85 $7.62 $7.63 $5.57 $5.78 $4.40
Tangible Book Value per Share
($17.42) $9.85 $7.62 $7.63 $5.57 $5.78 $4.40
Total Capital
34 321 251 372 273 408 312
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-37 -315 -238 -352 -248 -378 -292
Capital Expenditures (CapEx)
1.93 7.51 5.03 47 28 4.41 1.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-7.69 -4.91 -5.25 -14 -18 -13 -16
Debt-free Net Working Capital (DFNWC)
29 310 233 339 230 254 260
Net Working Capital (NWC)
29 310 233 339 230 254 260
Net Nonoperating Expense (NNE)
5.43 55 26 31 25 19 19
Net Nonoperating Obligations (NNO)
-37 -315 -238 -352 -248 -378 -292
Total Depreciation and Amortization (D&A)
0.38 1.52 4.99 1.82 -3.07 2.24 4.61
Debt-free, Cash-free Net Working Capital to Revenue
-6,687.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
25,478.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
25,478.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($5.44) ($2.62) $0.00 ($2.40) ($1.60) ($1.41)
Adjusted Weighted Average Basic Shares Outstanding
0.00 32.79M 33.00M 43.63M 49.01M 67.87M 73.99M
Adjusted Diluted Earnings per Share
$0.00 ($5.44) ($2.62) $0.00 ($2.40) ($1.60) ($1.41)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 32.79M 33.00M 43.63M 49.01M 67.87M 73.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($5.44) ($2.62) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 16.81M 32.86M 43.63M 49.42M 70.96M 71.29M
Normalized Net Operating Profit after Tax (NOPAT)
-16 -36 -61 -83 -92 -90 -85
Normalized NOPAT Margin
-13,603.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
-18,326.96% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-16.45 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-12.77 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-18.03 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-14.34 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Nkarta

This table displays calculated financial ratios and metrics derived from Nkarta's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
49,072,342.00 49,416,186.00 70,467,620.00 70,558,754.00 - 70,957,554.00 70,957,554.00 71,024,512.00 71,029,512.00 71,290,490.00 71,545,358.00
DEI Adjusted Shares Outstanding
49,072,342.00 49,416,186.00 70,467,620.00 70,558,754.00 - 70,957,554.00 70,957,554.00 71,024,512.00 71,029,512.00 71,290,490.00 71,545,358.00
DEI Earnings Per Adjusted Shares Outstanding
-0.56 -0.60 -0.36 -0.37 - -0.45 -0.33 -0.30 -0.39 -0.40 -0.57
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
14.70% 10.24% 21.86% -12.55% 1.64% -11.06% 13.66% 27.52% 3.85% 18.36% -57.37%
EBIT Growth
12.02% 4.42% 16.66% -15.50% 1.22% -10.97% 12.27% 24.35% 0.40% 15.65% -59.22%
NOPAT Growth
10.86% 4.52% 16.67% -15.36% 0.84% -11.60% 11.49% 19.26% -0.12% 15.56% -58.64%
Net Income Growth
14.82% 4.21% 24.92% -10.52% 6.55% -8.35% 8.07% 23.39% -5.68% 12.98% -75.69%
EPS Growth
9.52% 7.94% 50.00% 25.00% 49.12% 25.86% 8.82% 25.64% -31.03% 13.95% -74.19%
Operating Cash Flow Growth
-218.57% -37.33% -0.56% -21.06% -5.98% -3.88% 14.35% 23.87% 12.54% 4.77% -29.17%
Free Cash Flow Firm Growth
0.00% -8.55% 10.85% 11.49% 0.30% 10.25% 50.05% 51.64% 57.50% 51.98% 31.01%
Invested Capital Growth
25.08% 52.95% 58.28% 33.71% 20.46% 12.12% -9.93% -14.82% -34.04% -26.25% -72.31%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-4.38% -3.53% 6.76% -11.70% 8.78% -16.90% 27.51% 6.23% -21.02% 0.75% -39.73%
EBIT Q/Q Growth
-6.66% -4.98% 6.25% -10.03% 8.78% -17.94% 25.89% 5.12% -20.10% 0.11% -39.90%
NOPAT Q/Q Growth
-6.46% -5.06% 6.25% -10.02% 8.50% -18.24% 25.65% -0.37% -13.47% 0.27% -39.68%
Net Income Q/Q Growth
-8.22% -6.36% 15.33% -13.41% 8.50% -23.32% 28.16% 5.49% -26.22% -1.54% -45.04%
EPS Q/Q Growth
-9.62% -1.75% 41.38% -14.71% 25.64% -48.28% 27.91% 6.45% -31.03% 2.63% -45.95%
Operating Cash Flow Q/Q Growth
-15.19% -22.06% 23.20% -12.11% -0.84% -19.64% 36.67% 0.35% -15.84% -30.27% 14.10%
Free Cash Flow Firm Q/Q Growth
22.81% -19.46% -0.60% 4.57% 13.06% -7.54% 44.01% 7.60% 23.60% -21.51% 19.58%
Invested Capital Q/Q Growth
18.36% 5.37% 10.72% -3.16% 6.63% -1.93% -11.05% -8.43% -17.43% 9.65% -66.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
88.93% 90.09% 81.37% 83.87% 84.13% 87.96% 85.27% 84.93% 89.27% 90.75% 94.08%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-36.41% -28.33% -27.99% -30.40% -31.94% -26.10% -26.94% -26.69% -28.90% -30.07% -38.76%
Cash Return on Invested Capital (CROIC)
-430.41% -458.35% -408.38% -391.76% -342.95% -340.89% -312.76% -309.22% -299.42% -285.89% -436.60%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-36.41% -28.33% -27.99% -30.40% -31.94% -26.10% -26.94% -26.69% -28.90% -30.07% -38.76%
Return on Equity Simple (ROE_SIMPLE)
0.00% -24.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-22 -23 -22 -24 -22 -26 -19 -19 -22 -22 -30
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-1.97% -1.70% -0.97% -1.38% -1.37% -1.60% -1.05% -0.73% -1.71% -2.03% -3.56%
Return On Investment Capital (ROIC_SIMPLE)
-7.99% -4.84% -4.74% -5.49% -5.31% -6.76% -5.32% -5.65% -6.94% -7.56% -12.19%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-31 -33 -31 -34 -31 -36 -27 -26 -31 -31 -43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-31 -32 -30 -33 -30 -36 -26 -24 -29 -29 -41
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.19 1.13 0.92 0.74 0.43 0.34 0.33 0.44 0.42 0.53 0.82
Price to Tangible Book Value (P/TBV)
1.19 1.13 0.92 0.74 0.43 0.34 0.33 0.44 0.42 0.53 0.82
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.02 3.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.93 -0.95 -0.94 -0.93 -0.92 -0.93 -0.93 -0.93 -0.93 -0.92 -0.94
Leverage Ratio
1.32 1.26 1.27 1.29 1.29 1.23 1.24 1.25 1.26 1.27 1.30
Compound Leverage Factor
1.17 1.14 1.04 1.08 1.09 1.08 1.05 1.06 1.12 1.15 1.22
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.69 2.66 1.73 0.92 0.02 -0.47 -0.55 -0.49 -0.87 -1.07 -1.45
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
10.85 19.96 15.91 12.91 14.45 14.48 15.67 15.23 12.69 12.96 7.98
Quick Ratio
10.64 19.71 15.57 12.60 14.13 14.16 15.31 14.87 12.41 12.66 7.76
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-27 -32 -32 -31 -27 -29 -16 -15 -11 -14 -11
Operating Cash Flow to CapEx
-343.09% -16,289.14% -930.08% -3,158.94% -2,243.97% -5,716.60% -13,589.13% 0.00% -3,865.54% -6,827.85% -13,236.61%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
25 26 29 28 30 30 26 24 20 22 7.30
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
5.03 9.15 11 7.15 5.13 3.20 -2.91 -4.20 -10 -7.78 -19
Enterprise Value (EV)
76 87 -7.44 -84 -202 -219 -214 -167 -161 -114 -38
Market Capitalization
324 534 416 319 176 131 118 147 131 150 202
Book Value per Share
$5.57 $9.58 $6.43 $6.11 $5.78 $5.34 $5.04 $4.76 $4.40 $4.01 $3.46
Tangible Book Value per Share
$5.57 $9.58 $6.43 $6.11 $5.78 $5.34 $5.04 $4.76 $4.40 $4.01 $3.46
Total Capital
273 474 453 431 408 379 358 338 312 286 248
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-248 -447 -424 -403 -378 -349 -331 -314 -292 -264 -240
Capital Expenditures (CapEx)
6.81 0.18 2.35 0.78 1.10 0.52 0.14 -0.01 0.56 0.41 0.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-18 -17 -14 -15 -13 -13 -12 -12 -16 -13 -18
Debt-free Net Working Capital (DFNWC)
230 421 311 268 254 253 278 270 260 218 164
Net Working Capital (NWC)
230 421 311 268 254 253 278 270 260 218 164
Net Nonoperating Expense (NNE)
5.92 6.58 3.49 4.69 4.29 6.39 3.95 2.61 5.74 6.22 10
Net Nonoperating Obligations (NNO)
-248 -447 -424 -403 -378 -349 -331 -314 -292 -264 -240
Total Depreciation and Amortization (D&A)
0.23 0.69 0.81 0.39 0.35 0.73 1.12 1.35 1.40 1.59 2.27
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.57) ($0.58) ($0.34) ($0.39) ($0.29) ($0.43) ($0.31) ($0.29) ($0.38) ($0.37) ($0.54)
Adjusted Weighted Average Basic Shares Outstanding
49.01M 50.68M 73.49M 73.56M 67.87M 73.92M 73.98M 74.02M 73.99M 74.26M 74.49M
Adjusted Diluted Earnings per Share
($0.57) ($0.58) ($0.34) ($0.39) ($0.29) ($0.43) ($0.31) ($0.29) ($0.38) ($0.37) ($0.54)
Adjusted Weighted Average Diluted Shares Outstanding
49.01M 50.68M 73.49M 73.56M 67.87M 73.92M 73.98M 74.02M 73.99M 74.26M 74.49M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.42M 70.47M 70.56M 70.57M 70.96M 70.96M 71.02M 71.03M 71.29M 71.55M 71.62M
Normalized Net Operating Profit after Tax (NOPAT)
-22 -23 -22 -24 -22 -26 -19 -19 -22 -22 -30
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Nkarta’s latest financial statements show a well-funded but still pre-revenue biotechnology company facing persistent operating losses and ongoing cash burn. The company reported no revenue in the latest quarter or in any of the comparable income statements provided. Its Q2 2026 net loss attributable to common shareholders widened to $40.7 million, or $0.54 per share, from a $28.4 million loss, or $0.37 per share, in Q1 2026.

  • Substantial liquidity remains: Nkarta held approximately $240.1 million in cash, short-term investments and long-term investments at June 30, 2026. This provides a meaningful financial cushion for continued research and development.
  • Strong short-term balance-sheet position: Current assets of $188.0 million compared with current liabilities of $23.6 million imply a current ratio of roughly 8.0.
  • Quarterly operating cash burn improved sequentially: Net cash used in operating activities declined to $24.2 million in Q2 2026 from $28.2 million in Q1 2026.
  • Investments continue to generate interest income: Nkarta recorded $2.5 million of interest and investment income in Q2 2026, partially offsetting operating expenses.
  • Recent financing needs have been limited: Financing cash flow was positive by $676,000 in Q2 2026, while the company raised only modest amounts of equity in recent quarters compared with the $226.3 million equity-related inflow recorded in Q1 2024.
  • Investment portfolio activity is substantial: Nkarta purchased $42.4 million of investments and received $63.7 million from investment sales or maturities in Q2 2026. These transactions helped produce positive investing cash flow of $21.1 million, but they primarily reflect portfolio management rather than operating cash generation.
  • Liabilities have remained relatively stable: Total liabilities were $89.9 million in Q2 2026, compared with $90.6 million in Q2 2025 and $100.9 million in Q2 2024. The supplied statements show liabilities primarily classified as operating liabilities, although investors should review the full filings for details.
  • Nkarta remains entirely pre-revenue: Revenue and gross profit were reported as zero in the latest quarter and throughout the comparable periods supplied, leaving the company dependent on capital resources and future clinical or commercial progress.
  • Operating expenses are accelerating: Q2 2026 operating expenses rose to $43.1 million, up from $30.9 million in Q4 2025 and $27.2 million in Q2 2025. Research and development expense increased to $29.0 million, while selling, general and administrative expense rose to $14.1 million.
  • Accumulated losses and assets have worsened over time: Retained earnings declined to -$716.5 million in Q2 2026 from -$464.9 million in Q1 2024, while total assets fell to $337.6 million from $576.9 million over the same period. Continued losses are reducing the company’s equity cushion.

The cash-flow trend remains a key risk. Nkarta has reported negative operating cash flow in every comparable quarter provided, including $24.2 million in Q2 2026, $28.2 million in Q1 2026 and $21.6 million in Q4 2025. Although the company’s investment portfolio provides liquidity, the current statements do not show a path to self-funded operations.

Overall, Nkarta’s balance sheet still offers meaningful near-term support, but its investment case remains highly dependent on clinical execution and future financing or partnership opportunities. Retail investors should monitor the pace of research spending, quarterly operating cash burn, remaining liquid investments and any signs of revenue or milestone-related income.

10/16/26 01:10 AM ETAI Generated. May Contain Errors.

Nkarta Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nkarta's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Nkarta's net income appears to be on a downward trend, with a most recent value of -$104.08 million in 2025, falling from -$21.08 million in 2019. The previous period was -$108.79 million in 2024. Check out Nkarta's forecast to explore projected trends and price targets.

Nkarta's total operating income in 2025 was -$122.00 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $122.00 million

Over the last 6 years, Nkarta's total revenue changed from $115 thousand in 2019 to $0.00 in 2025, a change of -100.0%.

In the past 11 quarters, Nkarta's cash and equivalents has ranged from $24.96 million in Q2 2026 to $250.29 million in Q1 2024, and is currently $24.96 million as of their latest financial filing in Q2 2026.

Nkarta had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2019.

Over the last 6 years, Nkarta's book value per share changed from -17.42 in 2019 to 4.40 in 2025.



Financial statements for NASDAQ:NKTX last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners